West Pharmaceutical Services (WST) Intangibles (2009 - 2026)

West Pharmaceutical Services has disclosed Intangibles across 18 years of filings, most recently posting $7.0 million for Q1 2026.

• Intangibles for Q1 2026 came in at $7.0 million, down 30.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (down 30.0% YoY), and the FY2025 annual result was $7.7 million, down 28.7% from the prior year.
• Intangibles came in at $7.0 million for Q1 2026 at West Pharmaceutical Services, down from $7.7 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $21.8 million in Q1 2022 to a low of $7.0 million in Q1 2026.
• The 5-year median for Intangibles is $13.9 million (2024), against an average of $13.9 million.
• Across the five-year window, Intangibles tumbled 30.65% in 2022 and decreased 13.26% in 2023, its largest moves.
• West Pharmaceutical Services' Intangibles stood at $18.4 million in 2022, then decreased by 17.93% to $15.1 million in 2023, then decreased by 28.48% to $10.8 million in 2024, then declined by 28.7% to $7.7 million in 2025, then decreased by 9.09% to $7.0 million in 2026.
• The last three Intangibles figures came in at $7.0 million (Q1 2026), $7.7 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.